Imbrium, TetraGenetics announce research collaboration and license option to develop biologic therapeutics for pain

Image: Imbrium Therapeutics and TetraGenetics announce strategic research collaboration and license option to develop novel biologic therapeutics for pain. Photo: courtesy of Photokanok/FreeDigitalPhotos.net.